Single-Cell Analysis Market by Product {Consumables (Beads, Microplates, Reagents, and Others) and Instruments (Flow Cytometers, NGS Systems, PCR Instruments, and Others)}, Technique (Flow Cytometry, Next-generation Sequencing, Polymerase Chain Reaction and Other Techniques), Application {Research Applications (Cancer, Immunology, Neurology, Stem Cell, and Other Research Applications) and Medical Applications (Noninvasive Prenatal Diagnosis, In Vitro Fertilization, and Circulating Tumor Cell Detection)}, End Users (Academic & Research Laboratories, Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, and Cell Banks & IVF Centers): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00027077 | Pages: 100 | Industry: Medical Device | Date: Oct 2022 | Type: Global

The market crossed the US$ 3.5 billion mark in 2022 and is expected to hit US$ 7.5 billion by 2030, recording a CAGR of 15.0% during the forecast period.

Single-cell analysis market has been significantly growing due to increasing cases of cancer.

Cancer genomics is an important application of single-cell analysis. According to the American Cancer Society, about 19.3 million cancer cases and 10 million cancer deaths were reported in 2020 and it is expected to increase approximately to 30 million by 2040. Thus, growing cancer disease has resulted in extensive research for diagnosis and treatment which boosts the growth of the single-cell analysis market. The single-cell analysis provides a proper diagnosis of diseases and helps monitor treatment efficacy. It identifies helper T-cells, determines DNA content, and monitors tumor cell proliferation in breast cancer and other malignancies. The Consumables segment is expected to grow due to frequent purchases of these products and wider applications in research and genetic exploration, exosome analysis, and isolation of RNA and DNA. Thus, all these factors are expected to promote the growth of the single-cell analysis market.

Within the report, the market is segmented into product, technique, application, end users, and geography. By product type, the market is further segmented into consumables and instruments. On the basis of technique, the market is segmented into flow cytometry, next-generation sequencing, polymerase chain reaction, and other techniques. By application, the market is categorized into research and medical applications. Based on end users, the market is divided into academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and cell banks & IVF centers. Geographically, the market is sub segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

Get more information on this report :

Single-cell sequencing identifies disease-specific biomarkers which promote the growth of the single-cell analysis market.

Single-cell sequencing technology identifies disease-specific biomarkers which diagnose and monitor the disease occurrence and progress. It also monitors the patient’s response to the treatment. It provides genetic mutation details that help develop instruments and reagents for single-cell sequencers. Thus, due to high-growth potential, several single-cell sequencings are expected to be launched during the forecast period.

Increasing funds for life science research accelerates the market growth

There is an increasing fund for life science research and the increasing number of medical colleges, as well as universities, are expected to promote the growth of the single cell analysis market. Due to increasing diseases such as cancer and a wide range of chronic and infectious disorders, there is an increase in scientific projects employing single-cell analysis technology in research settings. Further, the introduction of spatial genomics accelerates the single-cell analysis in research activities which is expected to promote the growth of the single-cell analysis market. For instance, in June 2022, Stony Brook University developed single-cell cyclic multiplex in situ tagging technology, a biomedical research tool, that helps assess functional proteins in a single cell and assists in diagnostic and discovery fields.

Recent strategic developments in single cell analysis market

The single-cell analysis market has undergone several significant developments, and a few of these have been mentioned below:

  • In March 2021, Beckman Coulter launched CytoFLEX SRT Benchtop Sorter which is an expanded laser and color option for use in labs of all sizes.
  • In March 2020, Fluidigm Corporation along with the Singapore Immunology Network (part of the Agency for Science) opened a new Center of Excellence for Imaging Mass Cytometry in Singapore.

The single-cell analysis market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Becton, Dickinson and Company, Danaher Corporation, Merck KgaA, Qiagen, Thermo Fisher Scientific, Promega Corporation, Illumina Inc, Bio-Rad Laboratories, Fluidigm Corporation, and Agilent Technologies are among the prominent players operating in the market.

Target audience for the report:

  • Hospitals
  • Diagnostic Laboratories
  • Pharma companies
  • IVF centers
  • Research laboratories

Scope of the report:

In this report, the market has been segmented on the basis of:

  • Product
    • Consumables
      • Beads
      • Microplates
      • Reagents
      • Others
    • Instruments
      • Flow Cytometers
      • NGS Systems
      • PCR Instruments
      • Others
  • Technique
    • Flow Cytometry
    • Next-generation Sequencing
    • Polymerase Chain Reaction
    • Other Techniques
  • Application
    • Research Application
      • Cancer
      • Immunology
      • Neurology
      • Stem Cell
      • Other Research Application
    • Medical Application
      • Noninvasive Prenatal Diagnosis
      • In Vitro Fertilization
      • Circulating Tumor Cell Detection
  • End user
    • Academic & Research Laboratories
    • Biotechnology & Pharmaceutical Companies
    • Hospitals & Diagnostic Laboratories
    • Cell Banks & IVF Centers
  • Region
    • North America
    • Europe
    • Asia Pacific (APAC)
    • South & Central America
    • Middle East & Africa
  • Companies profiled
    • Becton, Dickinson and Company
    • Danaher Corporation
    • Merck KgaA
    • Qiagen
    • Thermo Fisher Scientific
    • Promega Corporation
    • Illumina Inc
    • Bio-Rad Laboratories
    • Fluidigm Corporation
    • Agilent Technologies

The List of Companies
- Becton, Dickinson and Company
- Danaher Corporation
- Merck KgaA
- Qiagen
- Thermo Fisher Scientific
- Promega Corporation
- Illumina Inc
- Bio-Rad Laboratories
- Fluidigm Corporation
- Agilent Technologies

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$1500
Site License
$2500
Enterprise License
$3500